(2E)-1-(4-methylphenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

4'-Fluoroacetanilide, 98.0%, 5g

tert-Butyl 3-(methoxymethyl)piperazine-1-carboxylate, 95.0%, 250mg

benzyl 2,9-diazaspiro[5.5]undecane-2-carboxylate hydrochloride, 10g

1-(3-Bromo-benzenesulfonyl)-piperazine, 95.0%, 250mg

(S)-2-Methyl-piperazine, 98.0%, 10g

Di-potassium oxalate monohydrate, min. 98.5%, pa, ACS, 1 kg, plastic packaging.

2-(3,4-Dihydro-2H-1,5-benzodioxepin-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 5g

tert-Butyl ((S)-1-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate, 98%, 10g

2,6-Difluoro-4-methoxypyridine, 95.0%, 250mg

1-(4-FLUOROPHENYL)-4-METHYL-1H-1,2,3-TRIAZOLE, 95.0%, 1g

1-([(TERT-BUTOXY)CARBONYL]AMINO)-1H-PYRROLE-2-CARBOXAMIDE, 95.0%, 2g

N-Boc-Morpholine-2-carboxylic acid, 95.0%, 100g